Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

4.61 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 528.216500.453594.35427.647476.124299.521394.796387.322405.87473.145549.912454.646453.875507.891285.116394.721632.738214.088262.126-69.883
Short Term Investments 00000000000061.56183.214231.446184.189000139.766
Cash and Short Term Investments 528.216500.453594.35427.647476.124299.521394.796387.322405.87473.145549.912454.646515.436591.105516.562578.91632.738214.088262.12669.883
Net Receivables 21.60646.12449.1662.2552.5262.5993.0943.1643.0512.0572.75311.63511.6811.3979.092.2820.0490.0710.1560
Inventory 00000002.2563.3251.3111.282.091.9011.5211.55210.23310.2325.0425.0410
Other Current Assets 37.33837.56870.75344.2745.50841.49543.47820.03622.09916.92317.14915.33718.8816.9539.06619.67814.8487.6634.1550
Total Current Assets 587.16584.145714.269474.172522.375343.615438.137410.522431.02492.125569.814481.618545.996619.455534.718600.87647.635221.822269.47869.883
Non-Current Assets:
Property, Plant & Equipment, Net 193.604204.777233.213159.189156.283122.217120.173120.31124.667125.12121.447119.503116.151104.00564.72555.43948.54944.64225.9670
Goodwill 164.27158.112148.87352.05652.05652.05652.05652.7560.5160.8010.8010.8010.8010.8010.8010.8010.8010.8010.8010
Intangible Assets 341.319335.79335.85534.09338.2133.07636.44339.45942.7571.3181.3061.4571.2331.3091.3851.4611.5371.6131.6890
Goodwill and Intangible Assets 505.589493.902484.72886.14990.26685.13288.49992.209103.2732.1192.1072.2582.0342.112.1862.2622.3382.4142.490
Long Term Investments 5.6290006.6296.6296.6297.6297.6297.927.928.1548.3348.7138.68100000
Tax Assets 0.9572.0031.93400036.443-7.629-7.629-7.92-7.92-8.154-8.334-8.713-8.68100000
Other Non-Current Assets 9.41620.40714.4546.9890.3080.254-36.1827.7847.7398.0027.928.1548.3340.0360.0350.0350.0683.0650.65-69.883
Total Non-Current Assets 715.195721.089734.329252.327253.486214.232215.562220.303235.679135.241131.474129.915126.519114.86475.62757.73650.95550.12129.107-69.883
Total Assets 1,302.3551,305.2341,448.598726.499775.861557.847653.699630.825666.699627.366701.288611.533672.515734.319610.345658.606698.59271.943298.5850
Liabilities & Equity:
Current Liabilities:
Account Payables 19.31425.08621.6132.263.7625.1153.9534.2652.0864.2474.5863.893.1764.1622.8196.3263.1963.1251.0740
Short Term Debt 32.21620.4422.2216.45225.3236.11712.27311.40511.1149.5416.04911.17710.5778.2641.5062.923.6342.6441.540
Tax Payables 0000000000000000000.2780
Deferred Revenue 39.6939.65161.76749.57932.20436.61836.42643.99773.10557.76156.72646.75363.78154.24710101010100
Other Current Liabilities 84.53856.80481.87240.59724.79426.0740.51934.45127.65420.60132.90421.21619.11919.03232.33325.11312.7111.08520.2070
Total Current Liabilities 164.026141.981187.472108.88886.08373.9293.17194.118113.95992.15100.26583.03696.65385.70546.65842.94329.5426.85423.0990
Non-Current Liabilities:
Long Term Debt 67.59172.4786.27274.17373.1644.85744.51545.42647.00547.9544.95646.55448.34947.9279.9724.11611.8512.89114.1220
Deferred Revenue Non-Current 126.2430118.765029.16937.39151.23851.38332.43657.09170.26193.90989.934107.1216.6679.16711.66714.16716.6670
Deferred Tax Liabilities Non-Current 23.78422.43716.5750.16821.070.5281.3391.9314.3361.1790.5360.5610.586-107.12104.547-6.687-11.289-18.1750
Other Non-Current Liabilities 1.565134.3994.73218.71130000000004.113.3482.8192.75450.9860
Total Non-Current Liabilities 219.183229.306226.34493.052105.32982.77697.09298.7483.777105.041115.217140.463138.283155.04820.74916.63126.336478.12481.7750
Total Liabilities 383.209371.287413.816201.94191.412156.696190.263192.858197.736197.191215.482223.499234.936240.75367.40759.57455.876504.974504.8740
Equity:
Preferred Stock 000000000000000658.606698.59448.312448.312201.109
Common Stock 0.0040.0040.0040.0030.0030.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.002000
Retained Earnings -1,805.589-1,633.694-1,431.283-1,252.377-1,156.535-1,058.995-967.622-874.626-781.609-704.883-639.556-582.064-521.619-456.059-400.08-335.147-287.719-244.318-213.6010
Accumulated Other Comprehensive Income/Loss 43.6214.145-7.637000-00000-0-0.197-0.309-0.1260.002-698.5900-124.265
Other Total Stockholders Equity 2,681.1112,553.4922,473.6981,776.9331,740.9811,460.1441,431.0561,312.5911,250.571,135.0561,125.36970.096959.393949.932943.142934.175930.43111.287-4410
Total Shareholders Equity 919.146933.9471,034.782524.559584.449401.151463.436437.967468.963430.175485.806388.034437.579493.566542.938599.032642.714-233.031-206.28976.844
Total Equity 919.146933.9471,034.782524.559584.449401.151463.436437.967468.963430.175485.806388.034437.579493.566542.938599.032642.714-233.031-206.28976.844
Total Liabilities & Shareholders Equity 1,302.3551,305.2341,448.598726.499775.861557.847653.699630.825666.699627.366701.288611.533672.515734.319610.345658.606698.59271.943298.58576.844